Legend Biotech Corp (LEGN) Free cash flow 2018–2025
Legend Biotech Corp (LEGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$128.8MFY2025 · since FY2018: $286.7M → -$128.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$128.8M | +18.5% |
| FY2024 | -$158.1M | +61.8% |
| FY2023 | -$413.4M | -86.0% |
| FY2022 | -$222.2M | +7.7% |
| FY2021 | -$240.7M | +3.4% |
| FY2020 | -$249.3M | -126.9% |
| FY2019 | -$109.8M | -138.3% |
| FY2018 | $286.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LEGN financial trends
LEGN RevenueLEGN Net incomeLEGN Net marginLEGN Gross profitLEGN Gross marginLEGN Operating incomeLEGN Operating marginLEGN Operating cash flowLEGN Capital expendituresLEGN Return on equityLEGN Stock buybacksLEGN Dividends paidLEGN Total assetsLEGN Total liabilitiesLEGN Shareholders’ equityLEGN overview →